Wu, X., Wang, X., Zhou, Y., He, Y., Qu, F., Chen, T. (2025). Carfilzomib Augmented with high-dose melphalan conditioning regimen Enhances Response in patients with multiple myeloma eligible for ASCT：an investigator-initiated, prospective, multicenter study. Blood. https://doi.org/10.1182/blood-2025-2256